Skip to content

Oruka Therapeutics, Inc. ORKA Market capitalization

Market capitalization at other companies

Bristol-Myers Squibb logo
Bristol-Myers SquibbBMY
$123.83B-0.2%
Eli Lilly logo
Eli LillyLLY
$821.68B+10.8%
Johnson & Johnson logo
Johnson & JohnsonJNJ
$588.76B+47.3%
Amgen logo
AmgenAMGN
$189.67B+13.3%
AbbVie logo
AbbVieABBV
$384.69B+3.8%
Kymera Therapeutics logo
Kymera TherapeuticsKYMR
$6.8B+283%

Other financials

Income statement

See full
Revenue-
Operating income-$36.4M-45.2%
Net income-$31.8M-51.5%
EPS (diluted)-$0.46+93.4%

Balance sheet

See full
Cash & equivalents$49.5M-40.7%
Total debt$1.8M+90.8%
Total equity$486.7M+33.4%
Total assets$504.5M+33.8%

Cash flow

See full
Operating cash flow-$23.6M-13.0%
CapEx$73.0K+462%
Free cash flow-$23.7M-13.3%

Valuation

See full
Enterprise value$4.32B+690%

Returns & leverage

See full
Return on equity-27.3%-11.1pp
Debt / equity0.0×
Current ratio23.8×-6.3×

Where this comes from

Computed from the period-end share price: $2.43B.

The official record: Oruka Therapeutics, Inc.’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →

Ask your AI about Oruka Therapeutics, Inc.'s market capitalization.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Oruka Therapeutics, Inc.'s market capitalization?
Oruka Therapeutics, Inc. (ORKA) reported market capitalization of $2.43B in Q1 2026.
How has Oruka Therapeutics, Inc.'s market capitalization changed year-over-year?
Oruka Therapeutics, Inc.'s market capitalization increased by 532.6% year-over-year, from $384.14M to $2.43B.
What does market capitalization mean?
The total market value of the company's equity at the quarter end (share price × shares outstanding), sampled from daily market data. The latest point tracks the live price.